Abstract Individual gene expression and molecular pathway activation profiles were shown to be effective biomarkers in many cancers. Here, we…
Abstract Treatment of metastatic disease remains among the most challenging tasks in oncology. One of the early events that predicts…
Abstract Inter-patient molecular heterogeneity is the major declared driver of an expanding variety of anticancer drugs and personalizing their prescriptions.…
Abstract DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dramatically in different cancer types…